Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Improved ability to identify symptoms of major depressive disorder (MDD) in general practice
Abstract:
The diagnosis and treatment of major depressive disorder (MDD) is a primary care responsibility in most countries, yet although most people with MDD present to their primary care team at some time during the course of their illness, the majority remain unrecognized and fewer still are effectively treated. Large-scale epidemiological studies have helped to identify several factors that influence recognition rates of MDD in primary care. Patients who present with psychological symptoms and clearly communicate their disability are more likely to be recognized than those who present with somatic symptoms or concurrent physical illnesses. Fatigue, loss of energy and poor motivation are core symptoms of depression in most patients, but are rarely interpreted as psychological symptoms and frequently mislead the primary care physician into searching for a somatic cause. If primary care recognition rates for MDD are to improve substantially, patients must be encouraged to seek help if they are suffering from these three core symptoms, and primary care physicians must increase their index of suspicion for MDD if a patient presents with them. Simple screening tools such as the Mini-International Neuropsychiatric Interview (MINI) can help to improve recognition rates significantly and should be applied routinely in primary care. ( Int J Psych Clin Pract 2001; 5 (Suppl 1): S3 - S10).
Related Concept Videos
Depressive Disorders: MDD and Dysthymia
Depression: Overview
Diagnostic and Statistical Manual of Mental Disorders (DSM)
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Antidepressant Drugs: MAOIs and Other Agents
Generalized Anxiety Disorder

